The Expert Committee decided that if India participates in GCT for NCE's to be used for diseases prevalent in our population, approval should be sought from CDSCO for marketing these NCEs in India after approval for marketing in the innovator country or in regulated markets.
Read MoreThe Expert Committee decided that if India participates in GCT for NCE's to be used for diseases prevalent in our population, approval should be sought from CDSCO for marketing these NCEs in India after approval for marketing in the innovator country or in regulated markets.
Read MoreDecided by the Expert Committee that there should be provision for providing ancillary care to patients suffering from any other illness during the trial.
Read MoreCliniExperts Services can assist the wholesale traders or manufacturers interested in importing small quantity of cosmetics into India for R&D and testing purpose
Read MoreRule 97 of Drug & Cosmetics Act 1945, provides for printing caution/ Warning in respect of drugs covered under Schedule H, Schedule G and substance covered under the purview of Narcotic & Psychotropic drugs Act, 1985 for the information of patients, doctors pharmacists and others so that there is no misuse of these drugs.
Read MoreThe Union health ministry has constituted two expert committees to formulate policy guidelines and standard operating procedures (SOPs) for approval of new drugs, clinical trials, banning of drugs and Fixed Dose Combinations (FDCs).
Read MoreZonal Licences (East, West, North and South Zone), State Licenses
Import and Registration of Medical Devices, Registration certificate of Critical / Notified Diagnostic Kits, Test licence for Medical Device and Diagnostic Kits, Import License for Diagnostic Kits, Manufacturing licence for medical device, Clinical Trial Approval for Medical Devices and Diagnostic Kits
Decided by the Expert Committee, the procedures for Clinical Trial approval, accreditations of investigators, sites, Ethics Committee and other conditions would be similar to the clinical trials of New Drug/ Vaccines.